Solid Biosciences, Inc.
(NASDAQ : SLDB)

( )
SLDB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.99%60.980.0%$944.37m
GILDGilead Sciences, Inc. 0.61%76.521.0%$773.37m
AMGNAmgen, Inc. 8.17%255.121.3%$748.85m
REGNRegeneron Pharmaceuticals, Inc. -2.32%609.172.5%$678.56m
NVAXNovavax, Inc. -1.51%78.50102.0%$597.80m
BIIBBiogen, Inc. -1.04%264.771.6%$543.38m
VRTXVertex Pharmaceuticals, Inc. -1.39%286.281.9%$524.18m
ILMNIllumina, Inc. -0.49%368.553.5%$308.59m
ALXNAlexion Pharmaceuticals, Inc. 0.13%112.392.0%$229.11m
BMRNBioMarin Pharmaceutical, Inc. 2.03%125.844.3%$214.73m
SGENSeattle Genetics, Inc. -1.41%167.526.1%$201.85m
SRNESorrento Therapeutics, Inc. 5.34%7.301.8%$196.91m
SRPTSarepta Therapeutics, Inc. 3.33%165.6813.9%$168.66m
INCYIncyte Corp. 0.01%102.662.5%$160.01m
IMMUImmunomedics, Inc. 4.15%36.9111.0%$154.32m

Company Profile

Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy. It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Arnold, Annie Ganot and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.